Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care

BDMD 12.16.2024

Full Press ReleaseSEC FilingsOur BDMD Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Baird Medical Expands into San Francisco, Advancing U.S. Market Growth
  • 01.21.2025 - Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care
  • 01.17.2025 - Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference

Recent Filings

  • 01.17.2025 - F-1/A Registration statement for certain foreign private issuers
  • 01.10.2025 - S-8 Securities to be offered to employees in employee benefit plans

NEW YORK,Dec. 16, 2024/PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session inNew Orleans. The program provided hands-on experience with a cutting-edge treatment that offers patients faster recovery times and effective relief from thyroid nodules.

Physicians Receive MWA Training Certification

Led byDr.Emad Kandil, Professor andEllis Hanna Chairin Surgery atTulane University School of Medicine, the program welcomedDr.Ernest O. Asamoah, an endocrinologist fromIndianapolis, IN, andDr.John W. Sistrunk, an endocrinologist fromJackson, MS.Both physicians observed seven live MWA cases, participated in in-depth discussions, and engaged in hands-on practice with the equipment.

Dr. Kandil, who has performed over 80 MWA procedures, recently presented at theAmerican Thyroid Association(ATA) annual meeting. He highlighted MWA's effectiveness compared to Radiofrequency Ablation (RFA) and shared clinical insights, stating, "MWA of thyroid nodules is a novel, safe, and effective method for treating appropriately selected patients."

The two endocrinologists also engaged in meaningful post-training discussions withDr. Kandil, gaining further insights into the transformative potential of MWA. Both physicians received Certificates of Completion, marking their enhanced proficiency and readiness to integrate MWA into their clinical practices.

"Investing in physician education is key to improving patient outcomes and expanding access to innovative treatments like MWA,"saidHaimei Wu, Chairwoman of Baird Medical. "By partnering with expert practitioners likeDr. Kandil, we empower clinicians to expand treatment options and improve outcomes in their communities."

Through targeted training programs, Baird Medical supports the adoption of innovative, minimally invasive therapies. These initiatives aim to connect expertise with technology, helping to expand access to patient-focused solutions and contribute to improved thyroid care outcomes.

About Baird MedicalBaird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visithttps://bairdmed.com/

Baird Medical (PRNewsfoto/Baird Medical LLC)

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/baird-sponsored-microwave-ablation-training-advances-innovation-in-thyroid-care-302332248.html

SOURCE BDMD

Eric Huang, PR Liaison, Baird Medical LLC, Phone: +1 (888) 508-6228, Email: erichuang@bairdmed.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com